IGC Pharma Inc (IGC)
0.43
-0.01
(-2.05%)
USD |
NYAM |
Apr 25, 16:00
0.422
-0.01
(-1.86%)
After-Hours: 07:58
IGC Pharma Free Cash Flow (Quarterly): -1.674M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.674M |
| September 30, 2023 | -1.673M |
| June 30, 2023 | -1.516M |
| March 31, 2023 | -1.687M |
| December 31, 2022 | -2.037M |
| September 30, 2022 | -1.588M |
| June 30, 2022 | -2.354M |
| March 31, 2022 | -1.469M |
| December 31, 2021 | -2.471M |
| September 30, 2021 | -2.347M |
| June 30, 2021 | -1.946M |
| March 31, 2021 | -2.624M |
| December 31, 2020 | -2.041M |
| September 30, 2020 | -2.769M |
| June 30, 2020 | -4.958M |
| March 31, 2020 | -2.716M |
| December 31, 2019 | -3.911M |
| September 30, 2019 | -2.467M |
| June 30, 2019 | -4.049M |
| March 31, 2019 | -1.159M |
| December 31, 2018 | -1.364M |
| September 30, 2018 | -0.324M |
| June 30, 2018 | -0.543M |
| March 31, 2018 | -0.862M |
| December 31, 2017 | -0.497M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.2472M |
| June 30, 2017 | -0.5258M |
| March 31, 2017 | -0.9249M |
| December 31, 2016 | 0.0694M |
| September 30, 2016 | -0.881M |
| June 30, 2016 | 0.1998M |
| March 31, 2016 | -0.2829M |
| December 31, 2015 | -0.0035M |
| September 30, 2015 | 0.5555M |
| June 30, 2015 | -0.549M |
| March 31, 2015 | 0.3498M |
| December 31, 2014 | -0.1885M |
| September 30, 2014 | -1.962M |
| June 30, 2014 | -0.8591M |
| March 31, 2014 | -0.8752M |
| December 31, 2013 | -0.451M |
| September 30, 2013 | -0.1723M |
| June 30, 2013 | -0.2436M |
| March 31, 2013 | -0.6948M |
| December 31, 2012 | 1.495M |
| September 30, 2012 | -0.1551M |
| June 30, 2012 | -0.0805M |
| March 31, 2012 | -3.826M |
| December 31, 2011 | -0.387M |
| September 30, 2011 | -0.3891M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.958M
Minimum
Jun 2020
-1.469M
Maximum
Mar 2022
-2.437M
Average
-2.347M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
| CEL-SCI Corp | -4.953M |
| AIM ImmunoTech Inc | -9.956M |
| NovaBay Pharmaceuticals Inc | -0.316M |
| Protalix BioTherapeutics Inc | 3.345M |
| Palatin Technologies Inc | -10.51M |